BS Flashcards
primary hemostasis
platelet plug formation at the site of vascular injury. (platelets are exposed to collagen, etc at injury site; leads to adherence, activation, aggregation of platelets; vWF assists platelets in adherence and bridges them together at site of injury)
secondary hemostasis
coagulation. conversion of fibrinogen to a fibrin clot.
vascular constriction in the clotting cascade
part of primary hemostasis. contraction of vascular smooth muscle in response to injury to slow blood flow to the area. occurs while platelet plug is forming.
conversion of prothrombin to thrombin in the clotting cascade
part of the common pathway. factor Xa converts prothrombin to thrombin. effects: activates fibrinogen to fibrin; positive feedback activation of intrinsic pathway; activates platelets
conversion of fibrinogen to fibrin in clotting cascade
part of the common pathway. catalyzed by thrombin. effects: activated platelets have a binding site for fibrinogen which helps form bridges between aggregating platelets.
formation of the platelet plug
primary hemostasis secondary to vessel injury. consists of platelets, vWF, Fibrinogen. temporary fix until “proper clot” forms
formation of a blood clot
platelet plug solidified by conversion of fibrinogen into fibrin. less temporary than platelet plug; prevents rebleeding.
fibrous organization of clot
fibrin cleaved into fibrin molecules; fibrin monomers crosslink to form net-like mesh that encases RBCs to prevent further spillage.
development of a blood clot
fibrinogen and other clotting components freely exist in circulation. without regulatory mechanisms, thrombin would continue to form clots everywhere. 3 major regulators control clot formation: antithrombin III, protein C, protein S.
sequence of events in blood clotting
- injury to the blood vessel wall or to the blood induces the formation of prothrombin activator.
- prothrombin activator catalyzes the change of prothrombin to thrombin.
- thrombin changes fibrinogen to fibrin, which mix w RBCs, platelets, and plasma to form clot.
- clot retraction
clot retraction
assisted by platelets, expresses serum. plasma can clot, serum cannot.
lysis of blood clots
plasmin cleaves fibrin resulting in breakup of the clot and creating fibrin products that inhibit thrombin.
major components of hemostasis
platelets, endothelial cells (lining the blood vessels), other tissue-factor bearing cells, and the coagulation factors (which are plasma proteins)
intrinsic pathway
requires negatively charged collagen inside the damaged endothelium to activate factor XII, which activates XI, then IX, then VIII, then leads to the common pathway
extrinsic pathway
initiated when factor VII contacts tissue factor released into the circulation from injured endothelium (a call for help from the injured tissue). this starts the common pathway by activating factor X with factor V, then factor II (prothrombin to thrombin), then factor I (fibrinogen to fibrin)
antithrombin
anticoagulant protein. produced in the liver. protease inhibitor: physically blocks the action of factor Xa and thrombin as well as factors IX and XI in the intrinsic pathway. activity enhanced when bound to heparin
protein S
anticoagulant protein. produced in the liver, vitamin K dependent. w/ cofactor protein C, inhibits factor Va and VIIIa. this protein “exposes” the site so that protein C can cleave the activated factor
plasminogen
promotes clot degradation. proenzyme that is cleaved to form plasmin, the main enzyme of fibrinolysis. activated plasmin digests fibrin, thus dissolving the clot.
tissue factor pathway inhibitor
protects against excessive coagulation. plasma protein secreted by endothelial cells. check and balance of the coagulation pathway. regulates max thrombin production.
clotting factors that are vitamin K dependent
II, VII, IX, X
anticoagulation factors
protein C, protein S, warfarin interferes w vitamin K atiity and therefore messes up clotting
viral hemorrhagic fever
associated w zoonotic viruses. prodrome of fever, myalgias, malaise. pts develop vascular damage, petichiae, and local hemorrhage. shock, multifocal hemorrhaging, and neuro signs predict a poor prognosis. related to increased vascular permeability and disseminated intravascular coagulation. vascular abnormalities may be d/t circulating virus antibody complexes which mediate compliment activation & release of vasoactive amines (the reason for this is unclear).